早期声门型喉鳞状细胞癌的调强放射治疗:系统综述与Meta分析
该系统综述与Meta分析纳入15项研究共2083例早期声门型喉鳞状细胞癌患者,其中873例接受调强放射治疗(IMRT),738例接受常规放射治疗(CRT)。IMRT后局部失败粗率为7.6%(95%CI 3.6%-11.5%),区域失败粗率为1.5%(95%CI 0.5%-2.5%);在同时报告两种模式结局的研究中,IMRT与CRT的局部失败和区域失败均无显著差异。作者结论指出回顾性数据提示两种治疗局部和区域控制相似,需要额外的前瞻性研究来确认IMRT的疗效。
要点
- IMRT后局部失败粗率为7.6%(95%CI 3.6%-11.5%),3年和5年 actuarial 局部失败率分别为6.3%和9.0%。
- IMRT后区域失败粗率为1.5%(95%CI 0.5%-2.5%)。
- 在同时报告两种模式结局的研究中,IMRT与CRT的局部失败(log OR;P=.12)和区域失败(log OR;P=.58)无显著差异。
核心结论
- 在早期声门型喉癌患者中,回顾性数据提示IMRT与CRT的局部和区域控制相似。
- 需要采用统一靶区勾画方法和图像引导的额外前瞻性研究来确认IMRT的疗效。
研究设计与样本
- 系统综述与Meta分析,检索Pubmed、Embase、Web of Science三个数据库2000年12月1日至2022年9月2日发表的文献。
- 纳入报告至少10例接受IMRT治疗的早期声门型喉癌患者结局的研究,共纳入15项研究(14项回顾性、1项前瞻性),合计2083例患者。
- 采用随机效应模型估计合并结局,数据提取和报告遵循PRISMA标准。
主要发现
- IMRT用于873例患者(64%为T1期,28%为T2期),采用了部分喉、单侧声带颈动脉保护等多种治疗技术和图像引导放射治疗技术。
- IMRT后局部失败粗率为7.6%(95%CI 3.6%-11.5%),3年和5年 actuarial 局部失败率分别为6.3%(95%CI 2.2%-10.3%)和9.0%(95%CI 4.4%-13.5%)。
- IMRT后区域失败粗率为1.5%(95%CI 0.5%-2.5%)。
- Meta回归分析显示,局部失败率升高与T2期疾病(P<.001)和2-3级组织学(P<.001)显著相关。
- CRT用于738例患者(76%为T1期,22%为T2期);在同时报告两种模式结局的研究中,IMRT与CRT的局部失败(log OR;P=.12)和区域失败(log OR;P=.58)无显著差异。
关键数值与推荐
- IMRT后局部失败粗率7.6%(95%CI 3.6%-11.5%),3年 actuarial 局部失败率6.3%(95%CI 2.2%-10.3%),5年 actuarial 局部失败率9.0%(95%CI 4.4%-13.5%)。
- IMRT后区域失败粗率1.5%(95%CI 0.5%-2.5%)。
- Meta回归分析中,局部失败率升高与T2期疾病(P<.001)和2-3级组织学(P<.001)显著相关。
- 同时报告两种模式结局的研究中,IMRT与CRT的局部失败(log OR;P=.12)和区域失败(log OR;P=.58)无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 纳入的15项研究中14项为回顾性研究,1项为前瞻性研究。
- 作者结论指出需要采用统一靶区勾画方法和图像引导的额外前瞻性研究来确认IMRT的疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Early-stage squamous cell carcinoma of the glottic larynx is commonly treated with 2-dimensional or 3-dimensional conventional radiation therapy (CRT). Despite its use in other head and neck cancers, intensity-modulated radiation therapy (IMRT) remains controversial in this patient population. METHODS AND MATERIALS: A systematic review was performed by querying 3 databases (Pubmed, Embase, Web of Science) for articles published between December 1, 2000 and September 2, 2022. Included studies reported outcomes in at least 10 patients treated with IMRT for early-stage glottic cancer. Data were extracted and reported following PRISMA standards. Pooled outcomes were estimated using random-effects models. Primary outcome was the rate of local failure (LF) following IMRT. Secondary outcomes included rates of regional failure (RF) following IMRT and rates of LF and RF following CRT. RESULTS: A total of 15 studies (14 retrospective, 1 prospective) consisting of 2083 patients were identified. IMRT was used in 873 patients (64% T1, 28% T2). Multiple treatment (partial larynx, single vocal cord carotid sparing) and image-guided radiation therapy techniques were used. The pooled crude rate of LF was 7.6% (95% confidence inverval [CI], 3.6%-11.5%) and actuarial LF rates at 3 and 5 years were 6.3% (95% CI, 2.2%-10.3%) and 9.0% (95% CI, 4.4%-13.5%), respectively. The pooled crude rate of RF after IMRT was 1.5% (95% CI, 0.5%-2.5%). On metaregression analysis, increased rate of LF was significantly associated with T2 disease (P < .001) and grade 2 to 3 histology (P < .001). Treatment with CRT was reported in 738 patients (76% T1, 22% T2). Among the studies reporting outcomes of both modalities, there was no significant difference in LF (log odds ratio; P = .12) or RF (log odds ratio; P = .58) between IMRT or CRT. CONCLUSIONS: In patients with early-stage glottic cancer, retrospective data suggests local and regional control are similar for patients treated with IMRT and CRT. Additional prospective studies with uniform methods of volume delineation and image guidance are needed to confirm the efficacy of IMRT.
引用
- Razavian NB, D'Agostino RB, Shenker RF, et al. Intensity-Modulated Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx: A Systematic Review and Meta-Analysis. Int J Radiat Oncol Biol Phys. 2023. PMID: 37150263. doi:10.1016/j.ijrobp.2023.04.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。